Medicare Enrolled

Dr. Dustin Higgins, D.O.

Endocrinology · Quincy, IL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1025 MAINE ST, Quincy, IL 62301
2172226550
In practice since 2010 (16 years)
NPI: 1306157409 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Higgins from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Higgins? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Higgins

Dr. Dustin Higgins is an endocrinology specialist in Quincy, IL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Higgins performed 1,565 Medicare services across 1,067 unique beneficiaries.

Between the years covered by Open Payments, Dr. Higgins received a total of $59,171 from 29 pharmaceutical and/or device companies across 684 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Higgins is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 32% volume in IL $59,171 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,565
Medicare services
Top 32% in IL for endocrinology
1,067
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
711 $87 $287
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
217 $25 $123
Diabetes self-management training, individual
Individualized education and training for managing diabetes, billed per 30-minute session.
157 $41 $149
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
126 $73 $460
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
107 $119 $445
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
45 $35 $246
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
44 $104 $502
Trabecular bone score calculation
This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk.
43 $26 $50
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $57 $194
Bone density scan (DEXA) of forearm, finger, hand, or foot
A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture.
20 $29 $129
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
18 $39 $49
New patient office visit, complex (60-74 min) 14 $145 $550
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $39 $117
Ultrasound-guided fine needle aspiration biopsy, each additional growth
This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session.
12 $47 $232
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
12 $68 $89
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$59,171
Total received (2018-2024)
Avg $8,453/year across 7 years
Top 9% in IL for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
684
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51,242 (86.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,905 (13.4%)
Other
Charitable contributions, space rental, and other categories
$24 (0.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,464
2023
$1,294
2022
$909
2021
$2,620
2020
$1,142
2019
$15,433
2018
$36,310

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$244
Lilly USA, LLC
$187
Corcept Therapeutics
$170
Xeris Pharmaceuticals, Inc.
$165
Abbott Laboratories
$160
AstraZeneca Pharmaceuticals LP
$152
Radius Health, Inc.
$99
Insulet Corporation
$70
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
Amgen Inc.
$53
Tandem Diabetes Care, Inc.
$48
ABBVIE INC.
$35
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 41.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$34,745
Lilly USA, LLC
$17,042
Horizon Therapeutics plc
$1,386
AstraZeneca Pharmaceuticals LP
$1,112
Abbott Laboratories
$1,053
Corcept Therapeutics
$631
SANOFI-AVENTIS U.S. LLC
$502
Insulet Corporation
$354
Janssen Pharmaceuticals, Inc
$317
Boehringer Ingelheim Pharmaceuticals, Inc.
$296
Tandem Diabetes Care, Inc.
$294
Xeris Pharmaceuticals, Inc.
$244
Medtronic MiniMed, Inc.
$198
Bayer Healthcare Pharmaceuticals Inc.
$183
Amgen Inc.
$152
Dexcom, Inc.
$128
Merck Sharp & Dohme Corporation
$105
Radius Health, Inc.
$99
Amarin Pharma Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$50
Alexion Pharmaceuticals, Inc.
$46
ABBVIE INC.
$35
IDx Techologies Inc.
$32
Welch Allyn
$24
Ultragenyx Pharmaceutical Inc.
$21
Optos, Inc.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
DEXCOM, INC.
$15
AbbVie Inc.
$12
Top 3 companies account for 89.9% of all-time payments
Associated products mentioned in payments ›
BAQSIMI · CYCLOSET · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Freedom Lite system · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · HUMULIN U · INVOKAMET · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · Levemir · MOUNJARO · Minimed 630G · Minimed 670G System · None · Omnipod · Ozempic · PANORAMIC OPHTHALMOSCOPE · Prolia · RECORLEV · RYBELSUS · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SYNTHROID · Saxenda · Strensiq · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tresiba · Tymlos · Vascepa · Victoza · Wegovy · XARELTO · iPro2 · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for endocrinology in IL.

Looking for an endocrinology specialist in Quincy?
Compare endocrinologists in the Quincy area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
4
Per 100K population
6.1
County median income
$64,962
Nearest hospital
BLESSING HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Higgins is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 9% of IL peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Higgins experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Higgins performed 711 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Higgins receive payments from pharmaceutical companies?
Yes. Dr. Higgins received a total of $59,171 from 29 companies across 684 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Higgins's costs compare to other endocrinologists in Quincy?
Dr. Higgins's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Higgins) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →